Logistics and freight stocks fell on Feb. 12 amid growing AI-related selling pressure. C.H. Robinson (CHRW) and Universal Logistics (ULH) traded sharply lower after Algorhythm Holdings (RIME) announced an AI platform it claims can scale freight volumes without adding headcount, citing a 4x improvement in workforce productivity. RIME shares surged as high as 79% before closing up 29%, while shares of Maersk (MAERSK-B.CO), UPS (UPS), and Hub Group (HUBG) also declined.

The broader market reflected sector rotation: financials, real estate, and software shares were hit by similar AI-driven disruption fears. On Thursday, the Nasdaq Composite (^IXIC) fell 2%, the S&P 500 (^GSPC) lost 1.5%, and the Dow Jones Industrial Average (^DJI) dropped 1.3%.

Nearly three-quarters of S&P 500 companies now identify AI as a material risk, up from 12% in 2023, according to a Conference Board study. As AI integration accelerates, volatility is spreading across multiple corners of the market.

Wynn Resorts (WYNH) will hold its Q4 2025 earnings conference call at 4:30 PM Eastern Time on February 13, 2026. The call will provide an update on fourth-quarter results, including revenue, operating income, and guidance for 2026. The company will review its performance amid the ongoing impact of the Las Vegas market and global travel trends. A live webcast will be available on the company’s investor relations page, with a replay accessible via the same channel.

DexCom (DXCM) will host its Q4 2025 earnings conference call at 4:30 PM ET on February 13, 2026. The call will review fourth-quarter and annual financial results, including revenue, gross profit, and EPS. The company will also discuss guidance for 2026 and address product updates, including the latest iteration of its continuous glucose monitoring system. A live webcast and replay will be available on the company's investor relations page.

Eurozone stocks closed mixed on February 12, with the EURSTOXX 600 down 0.4% and the FTSEuro Stoxx 300 down 0.2%. The ECB's upcoming policy meeting on February 14 is expected to weigh on sentiment, with investors eyeing potential rate hikes and clarity on monetary easing timelines. Yields on German 10-year bunds rose to 3.85%, up 12 bps from the prior day, reflecting tightening bond markets. The mixed close followed a清淡 session in London and Paris, with FTSE 100 and CAC 40 indices both trading lower by the close.

IBM announced it will triple U.S. entry-level hiring in 2026, despite pressure on broader demand for early-career roles due to advancing AI. The company, which did not provide exact numbers, said the expansion will be across departments and reflect a redesigned job mix.

CHRO Nickle LaMoreaux said AI is handling more routine coding, shifting junior developers’ focus to customer-facing work, and HR interns to oversight of chatbots. She cautioned that cutting early-career recruitment risks mid-level talent shortages and may drive up attrition from competitor poaching.

The move contrasts with warnings that AI could displace up to half of office entry-level roles by 2030. Dropbox is expanding its internship programs by 25% for similar reasons, emphasizing the AI fluency of younger workers.

DexCom (NASDAQ:DXCM) reported Q4 CY2025 revenue of $1.26B, up 13.1% YoY, and non-GAAP EPS of $0.68, 4.5% above consensus. Organic revenue growth over the past two years averaged 14.1% YoY, core operations drove most of the results, and the operating margin expanded 8.7 pp to 25.6% in Q4. Analysts project full-year 2026 revenue of $5.21B and EPS of $2.09, up 18.4% from 2025.

Key context: The company’s five-year CAGR for revenue is 19.3%, EPS is 22.1%, and operating margin is 15.7% (with 8.7 pp expansion over the five-year period and a 4.4% share count reduction). Despite a moderation in two-year growth, strong fundamentals, healthy margins, and consistent EPS expansion suggest continued demand for its continuous glucose monitoring systems.

The Consumer Financial Protection Bureau terminated program manager Alexis Goldstein after an acting deputy chief of staff confirmed she was fired for disrupting and documenting a 2025 meeting with Elon Musk’s Department of Government Efficiency. Emails show Goldstein used her personal phone to photograph computers, confronted and yelled at CFPB IT director Tom McCarthy, and sought to verify credentials of unfamiliar visitors. The National Treasury Employees Union defended her as attempting to protect sensitive data, while a CFPB spokesperson said her actions were “inappropriate and unbecoming of a federal worker,” citing a December memo that had already proposed her removal. Goldstein, hired as a time-limited fellow, alleged retaliation for履职 and protecting trade secrets and sensitive data.

Applied Materials (NASDAQ:AMAT) reported Q4 CY2025 revenue of $7.01 billion, 2.1% below year-on-year, but 1.8% above analyst estimates. Non-GAAP EPS of $2.38 per share was 7.8% above consensus. Guidance for fiscal 2026’s first quarter is $7.65 billion at the midpoint, 8.1% above expectations.

Supporting context: The company’s 5-year CAGR of sales is 9.2%, above sector average, but 2-year annualized growth slowed to 3.2%. Days Inventory Outstanding (DIO) rose to 153, 12 days above the 5-year average, signaling higher inventory levels and potential softening demand.

Following the earnings, AMAT’s stock rose $7.00 to $347.00, a 5.5% gain.

Applied Materials (AMAT) reported on Friday, February 13, 2026, that it forecast second-quarter revenue and adjusted profit above estimates, led by heightened demand for AI processors and manufacturing expansion. The company anticipates Q2 sales of about $7.65 billion (±$500 million), versus $7.01 billion, and adjusted profit of about $2.64 per share (±$0.20), versus $2.28 per share, according to LSEG data. The positive guidance drove its shares up 9% in extended trading.

Applied Materials Inc. (AMAT) released fiscal first-quarter results on February 12, 2026, reporting earnings of $2.03 billion and adjusted earnings of $2.38 per share, topping Zacks analysts’ $2.19 per share estimate. Revenue reached $7.01 billion, exceeding the $6.89 billion forecast. For the quarter ending April 30, the company guided to per-share earnings of $2.44–$2.84 and revenue of $7.15B–$8.15B. AMAT shares closed at $330.33, up 29% year-to-date, reflecting strong outperformance compared to the S&P 500’s near-flat start to 2026.

Airbnb (ABNB) reported on February 12, 2026, that it forecast first-quarter revenue of $2.59 billion to $2.63 billion, exceeding the $2.53 billion average estimate from analysts. The outlook reflects strength in premium and luxury bookings as cost-conscious travelers decline amid inflation and economic uncertainty.

The company anticipates 2026 revenue growth of at least double digits, higher than the 10.24% median estimate. It noted that Q4 experiences bookings were not always tied to accommodation, and it is expanding into hotels in cities such as New York and Madrid to broaden its addressable market.

Q4 results showed EPS of 56 cents versus 73 cents a year earlier, and revenue of $2.78 billion versus $2.71 billion, as it continues to invest in marketing, product and technology.

Midad Energy, a Saudi-backed energy firm, has signed a term sheet to acquire Lukoil’s sanctioned offshore assets, outbidding rivals including Carlyle Group. The all-cash deal is conditional on U.S. regulatory approval and is placed in escrow to navigate sanctions compliance.

The agreement covers oilfields, refineries, and thousands of fuel stations globally. Midad is leveraging strong political connections with Saudi Arabia, while the U.S. Treasury has issued temporary general licenses allowing divestment wind-downs under strict conditions. Explicit U.S. authorization is still required, and geopolitical tensions, including the ongoing Russia-Ukraine conflict, add uncertainty.

Lukoil is actively seeking to offload foreign operations hit by U.S. sanctions, with buyers and sellers using escrow mechanisms to await government sign-off.

Datadog (DDOG) surged 13.9% on Tuesday following a Q4 and full-year 2025 earnings report that beat estimates and signaled strong 2026 growth. The stock dipped slightly since then but remains under upbeat analyst sentiment.

Key highlights: Q4 revenue $953M (+29 YoY); EPS $0.59 (+20 YoY); ARR of 4,310 customers ≥$100K, +19 YoY; 603 customers ≥$1M ARR, +31 YoY. For Q1 revenue guidance $951–$961M and 2026 revenue $4.06–$4.10B, EPS $2.08–$2.16.

Analysts rate DDOG a “Strong Buy” (35 of 42), average price target $190.25, implying ~55% upside from current levels. AI integrations, including Bits AI Agents, LLM Observability enhancements, MCP, and Toto, continue to drive demand.

CoreCivic (NYSE:CXW) posted Q4 CY2025 revenue of $604 million, up 26% year-on-year, and GAAP earnings of $0.26 per share, 30.9% above consensus. The results exceeded expectations despite a negative market reaction.

The outperformance stemmed from a more than 100% year-on-year revenue increase from Immigration and Customs Enforcement (ICE) due to new contracts and higher detention populations, partially offset by a population decline in the U.S. Marshals Service. Management expects continued growth from pending facility activations, including the Midwest Regional Reception Center pending regulatory approval, with stabilized occupancy in reactivated sites like California City and Diamondback.

Looking ahead, guidance hinges on ICE and state-level demand, facility activations, and potential acquisitions. The stock closed at $17.75, down from $18.50 pre-earnings.

Ameris Bancorp (ABCB) reported Q4 revenue in line with expectations, driven by higher net interest income and disciplined expense management, with year-over-year loan growth and strong Southeast market conditions supporting performance. The company delivered record 2025 earnings of over $412 million and a diluted EPS of $6.

Analysts will closely watch: (1) whether core loan production outpaces regional peers; (2) how deposit growth and pricing strategies affect the net interest margin amid evolving competition; and (3) the resilience of asset quality under shifting lending conditions. Execution on expense controls and selective hiring will be key to sustaining profitability.

ABCB closed at $83.49, up from $81.30 before the earnings. (February 12, 2026)

Memory prices are climbing amid persistent supply constraints, sending Micron Technology (MU-US) higher on renewed demand outlooks. Lenovo Group (0992.HK) said memory prices rose 40%–50% in the last reporting period, with contract prices potentially doubling this quarter, and shortages expected to last through the year.

In related trading, Micron rose about 4% in early trade and closed up 0.88% to $413.97 per share. The firm supplies DRAM to Lenovo, making Lenovo’s commentary a key barometer of pricing power and demand momentum.

Activity in high-bandwidth memory (HBM) continued, with Micron executive Mark Murphy stating HBM4 production is accelerating and ahead of schedule, and the product meets key performance standards. Analysts note AI infrastructure expansion, including from Google Cloud and Amazon AWS, is boosting memory demand as vendors like Seagate (STX-US) and Western Digital (WDC-US) raise prices and introduce higher-density, higher-priced offerings.

However, Klein & Co. warns PC and mobile OEMs are absorbing the cost, with potential price passes to consumers and demand weakness if supply outpaces demand, posing a near-term risk.

Bio-Rad Laboratories (BIO) will host its Q4 2025 earnings conference call at 5:00 PM Eastern Time on February 13, 2026. The call is scheduled to review the company's financial results for the quarter ended December 31, 2025, including revenue, gross profit, and EPS guidance for 2026. Management will discuss operating performance, key business drivers, and strategic initiatives. The live webcast will be available on the company's investor relations website, with a replay accessible via the same platform.

Eli Lilly reported $1.5 billion in pre-launch inventory for orforglipron, its experimental oral weight-loss drug, as of its latest filing, ahead of a potential FDA decision in April 2026.

The buildup follows a nearly $550 million inventory in 2025 and reflects the company’s intent to launch the drug in multiple countries simultaneously if approved. Novo Nordisk’s once-daily weight-loss pill began selling over 26,000 prescriptions in its second full week in the U.S., per IQVIA data shared by an analyst.

Orforglipron received a fast-track review voucher that could reduce the review timeline to 1–2 months from the typical 10–12 months for most new medicines. Such pre-launch assets are recorded on balance sheets to indicate the amount of drug product manufactured before approval.

Didero (DIDR) raised $30 million in Series A funding co-led by Chemistry and Headline, with participation from Microsoft’s M12, to automate end-to-end global manufacturing procurement. The agentic AI platform sits atop existing ERP systems, ingesting fragmented communications across emails, WeChat, and purchase orders to automatically execute sourcing, negotiation, order tracking, and payments. The company serves manufacturers and distributors, aiming to replace manual processes with autopilot execution from quote to payment. Didero claims to address a full procurement workflow not yet fully covered by its smaller competitors, with a growing customer base including Footprint, a provider of sustainable plant-based packaging.

Elevated short interest—33.4% of UA’s float—positions the stock for a potential short squeeze after a Q3 fiscal 2026 earnings beat lifted shares to a 52-week high of $7.70. On Feb. 6, revenue rose to $1.33B (vs. $1.31B estimate), and adjusted EPS to $0.09 (vs. -$0.20/eps loss), despite a 5.2% YO/Y revenue decline and 10% NA weakness. International sales advanced 3%, led by 20% growth in Latin America. The company closed with $464.6M in cash, retired $600M in senior notes, and raised full-year revenue guidance downshift to about -4% and EPS to $0.10-$0.11.

On Feb. 10, Citi downgraded UA to “Sell” at $6.20 citing North America headwinds, sending shares down 10.7%. Valuation remains attractive at 0.60x sales, with 26% average upside to the $8.50 Street average and 63% to the $11 UBS high. Williams Trading raised its price target to $10 from $8 while maintaining a “Buy” rating, suggesting a potential continuation of the short squeeze.